Zavesca (Actelion Pharmaceuticals US, Inc.)
Welcome to the PulseAid listing for the Zavesca drug offered from Actelion Pharmaceuticals US, Inc.. This Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actelion Pharmaceuticals US, Inc. |
NON-PROPRIETARY NAME: | miglustat |
SUBSTANCE NAME: | MIGLUSTAT |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-07-31 |
END MARKETING DATE: | 0000-00-00 |
Zavesca HUMAN PRESCRIPTION DRUG Details:
Item Description | Zavesca from Actelion Pharmaceuticals US, Inc. |
LABELER NAME: | Actelion Pharmaceuticals US, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2003-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66215-201_fc629ed9-b52c-4dad-8a09-89e65b277ff7 |
PRODUCT NDC: | 66215-201 |
APPLICATION NUMBER: | NDA021348 |
Other MIGLUSTAT Pharmaceutical Manufacturers / Labelers: